Alto Neuroscience, Inc.
ANRO
$24.63
$0.100.41%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 14.30% | -20.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.07% | -19.97% | |||
| Operating Income | -14.07% | 19.97% | |||
| Income Before Tax | -14.11% | 19.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -14.11% | 19.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.11% | 19.91% | |||
| EBIT | -14.07% | 19.97% | |||
| EBITDA | -14.28% | 20.13% | |||
| EPS Basic | 9.52% | 20.00% | |||
| Normalized Basic EPS | 9.51% | 20.01% | |||
| EPS Diluted | 9.52% | 20.00% | |||
| Normalized Diluted EPS | 9.51% | 20.01% | |||
| Average Basic Shares Outstanding | 26.12% | 0.12% | |||
| Average Diluted Shares Outstanding | 26.12% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||